We are happy to announce the addition of 10 new tests to our Spotlight™ Panel line, which provides clinicians a targeted approach to genetic testing when a patient's symptomatology is discernible. Each Spotlight Panel contains between approximately 3 to 50 genes selected to address a group of disorders with overlapping symptoms, making test selection clear and straightforward.
The new Spotlight tests will address nine neuromuscular disorders and one endocrine disorder:
- Bardet-Biedl Syndrome
- Centronuclear Myopathy
- Congenital Muscular Dystrophy
- Congenital Myasthenia
- Congenital Myopathy
- Distal Myopathy
- Hereditary Spastic Paraplegia
- Limb-Girdle Muscular Dystrophy
- Myofibrillar Myopathy
- Myopathy with Contractures
We are happy to offer this expansion to our test menu in just a month since our last announcement. Our rapid development engine enables Courtagen to address the testing needs of our ordering physicians and institutions quickly. We expect to significantly expand our test offerings over the course of 2017, so stay tuned for more announcements!